Operating income decreased 12.5%
Operating income changed -12.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -12.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +1468 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +297 basis points from the comparable as-filed period.
Gross profit changed +15.8% from the comparable as-filed period.
Net income changed -15.7% from the comparable as-filed period.
Debt / assets changed -3587 basis points from the comparable as-filed period.
Gross margin changed +24 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -31432 basis points from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Cost of revenue changed +14.2% from the comparable as-filed period.
Current assets changed +5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.